How to Measure Pentose Phosphate Pathway Flux
What Has to Be Specified First
Before choosing a method, three things determine what can be measured.
| Question | Why it changes the method |
|---|---|
| Oxidative or non-oxidative branch? | Only the oxidative branch releases CO₂ from C1 |
| Net flux or exchange? | The non-oxidative branch is reversible; exchange can be high with no net flux |
| Whole cell or compartment? | The PPP is cytosolic; mitochondrial contributions must be excluded by design |
Important distinction. Net flux and exchange are different quantities. Transketolase and transaldolase can carry large bidirectional fluxes with little net carbon movement, and a method that measures net ribose production cannot see the exchange. Claims about "PPP activity" should say which of the two is meant.
Part 1 — The Four Methods
| Method | Branch measured | Assumption | Limitation |
|---|---|---|---|
| ¹⁴CO₂ or ¹³CO₂ from [1-¹⁴C]/[1-¹³C]glucose | Oxidative | Released CO₂ reflects 6PGD decarboxylation | Recycling of label through the non-oxidative branch under-reports |
| C1/C6 oxidation ratio | Oxidative relative to glycolytic plus TCA | C6 oxidation reports mitochondrial activity | Distorted when respiration is low or glutamine-driven |
| Ribose labelling from ¹³C-glucose | Total ribose synthesis | Labelled ribose came from glucose | Does not partition oxidative from non-oxidative |
| Positional isotopomer analysis | Both branches, with a model | A network and reversible exchange parameters are correct | Requires modelling expertise and multiple labelled tracers |
Readout note. The C1/C6 ratio is the field's default and the most assumption-laden. It works well in glycolytic, respiration-competent cells and poorly in cells with high glutamine anaplerosis or with a reversed non-oxidative branch. Reporting it alone, without a second method, is the most common weakness in PPP papers.
Part 2 — Practical Design for the C1/C6 Method
| Parameter | Requirement |
|---|---|
| Tracer | [1-¹⁴C]glucose and [6-¹⁴C]glucose, or the ¹³C equivalents with CO₂ capture |
| CO₂ collection | Sealed vessels with a hydroxide trap; efficiency validated |
| Incubation time | Long enough for measurable release, short enough to avoid recycling |
| Glucose concentration | Identical across conditions; it sets the flux |
| Cell number | Matched; the ratio is normalised to it |
| Parallel measurement | At least one other PPP readout |
Caveat on CO₂ trapping. Collection efficiency is the most common technical failure: an incompletely sealed vessel gives a low, variable signal that looks like low flux. A standard curve of ¹⁴CO₂ release from a known amount of labelled bicarbonate validates the trap.
Part 3 — Ribose Labelling and What It Adds
Ribose labelling measures total ribose synthesis, which is the sum of oxidative and non-oxidative contributions.
- • Use it as a numerator check: if ribose labelling rises while C1 oxidation does not, the non-oxidative route is supplying the ribose.
- • Use it with proliferation data: ribose demand tracks nucleotide synthesis, so a labelling change in a treatment that also changes proliferation is ambiguous.
- • Do not use it alone for a branch claim. It cannot partition by itself.
The informative combination is C1 oxidation (oxidative branch) plus ribose labelling (total), which constrains the non-oxidative contribution by difference — provided the assumptions about recycling are stated.
Part 4 — When Positional Analysis Is Required
Positional isotopomer analysis is the only approach that resolves both branches and exchange, and it requires:
- • Multiple tracers (for example [1,2-¹³C]glucose and [U-¹³C]glucose), because a single tracer does not constrain a reversible network.
- • A metabolic network model including the PPP, glycolysis and the reversible exchange reactions.
- • A fitting procedure with an assessment of identifiability — whether the data can distinguish the parameters claimed.
- • Extracellular rates if absolute fluxes are claimed rather than relative ones.
Important distinction. Isotopomer fitting without an identifiability assessment can return precise-looking parameters that the data do not constrain. Reporting confidence intervals, or a sensitivity analysis, distinguishes a flux estimate from a curve fit.
Part 5 — What Each Claim Requires
| Claim | Minimum evidence | What does not count |
|---|---|---|
| "Oxidative PPP flux increased" | C1 oxidation plus one independent measurement | G6PD mRNA or lysate activity |
| "Non-oxidative flux increased" | Positional analysis, or a transketolase perturbation with a labelling readout | Total ribose labelling |
| "PPP supplies NADPH for a process" | PPP flux change plus a NADPH-dependent phenotype plus a rescue | A correlation between the ratio and the phenotype |
| "The PPP is required for proliferation" | G6PD or transketolase loss plus a proliferation phenotype plus ribose or nucleoside rescue | Growth difference at baseline |
The fourth row's rescue is the discriminating step: if ribonucleosides restore proliferation, the requirement is for ribose supply rather than for NADPH, and the mechanistic interpretation changes.
Part 6 — Common Failures
- • C1/C6 ratio reported as branch-specific flux in a glutamine-dependent model.
- • CO₂ trapping not validated, giving a systematic underestimate.
- • Incubation long enough for label recycling, which flattens the ratio.
- • Ribose labelling reported as oxidative flux.
- • G6PD activity in lysate reported as pathway flux.
- • Proliferation not measured, although ribose demand follows it.
- • Isotopomer model without an identifiability check.
- • Glucose concentration differing between conditions, changing flux and labelling together.
Part 7 — Where This Article Connects
This is the method-level companion to the PPP and NADPH article, which covers the branch logic and the NADPH sources. The glucose tracing discussion in the pillar covers the general principles of isotopologue interpretation, and the glycogen article covers the competing glucose-6-phosphate branch.
If you need PPP flux resolved by branch with validated CO₂ trapping, we can scope the design with you.
Contact EDITGENE to request a project consultation or quote.
Scientific scope and validation note
PPP flux, branch balance and NADPH production vary with cell type, proliferation rate and oxidative challenge; the methods here measure what their assumptions permit, not an assumption-free flux.
A labelling pattern or an oxidation ratio does not establish absolute flux without extracellular rates and a validated model.
Scientific interpretation and experimental design
- • Specify the branch before the method. Oxidative and non-oxidative need different designs.
- • Net flux is not exchange. The reversible branch carries both.
- • Validate the CO₂ trap. Collection efficiency is the usual failure.
- • C1/C6 needs a companion measurement.
- • Ribose labelling is total, not oxidative.
- • Identifiability must be assessed for isotopomer fits.
- • Rescue tells you which product mattered.
Selected references for further reading
- • Katz J, Wood HG. The use of glucose-C¹⁴ for the evaluation of the pathways of glucose metabolism. Journal of Biological Chemistry. 1960;235:2165–2177.
- • Buescher JM, et al. A roadmap for interpreting ¹³C metabolite labeling patterns from cells. Current Opinion in Biotechnology. 2015;34:189–201.
- • Chen L, et al. NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism. Nature Metabolism. 2019;1:404–415.
- • Antoniewicz MR. A guide to ¹³C metabolic flux analysis for the cancer biologist. Experimental & Molecular Medicine. 2018;50:1–13.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »